Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T helper type 2 (Th2) response is a specialized arm of the adaptive immune system, primarily mediated by CD4+ Th2 cells. It orchestrates humoral immunity, crucial for defense against extracellular parasites and central to allergic diseases. Enhancement of this pathway leads to increased antibody production, eosinophil recruitment, and mucus hypersecretion. Therapeutic modulation involves targeting key cytokines and effector cells.
Varies depending on the targeted component; examples include blocking cytokine receptors (dupilumab), depleting eosinophils (mepolizumab/reslizumab), and stabilizing mast cells (cromolyn sodium).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T helper type 2 (Th2) Response (Th2 Response).